Login / Signup

Exploring the role of botulinum toxin in critical care.

Muhammad Ubaid HafeezMichael MooreKomal HafeezAbhishek Lenka
Published in: Expert review of neurotherapeutics (2021)
The use of BoNT in this setting is largely underutilized due to paucity of well-designed clinical trials and financial barriers. Further research is needed to provide evidence for the safety and efficacy of BoNT and to optimize the dosing and injection techniques for various conditions encountered in this setting.
Keyphrases
  • botulinum toxin
  • clinical trial
  • ultrasound guided
  • healthcare
  • phase ii
  • young adults
  • phase iii
  • affordable care act